f DHA and Cancer: The Uncharted Territory of Nutritional Oncology

References

1. CalderP.C. Docosahexaenoic acid.Ann. Nutr. Metab.20166982110.1159/00044826227842299
   [Google Scholar]
2. NewellM. BakerK. PostovitL. FieldC. A critical review on the effect of docosahexaenoic acid (DHA) on cancer cell cycle progression.Int. J. Mol. Sci.2017188178410.3390/ijms1808178428817068
   [Google Scholar]
3. MolfinoA. AmabileM. MontiM. ArcieriS. FanelliR.F. MuscaritoliM. The role of docosahexaenoic acid (DHA) in the control of obesity and metabolic derangements in breast cancer.Int. J. Mol. Sci.201617450510.3390/ijms1704050527058527
   [Google Scholar]
4. YangY.C. LiiC.K. WeiY.L. LiC.C. LuC.Y. LiuK.L. ChenH.W. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways.J. Nutr. Biochem.201324120421210.1016/j.jnutbio.2012.05.00322901690
   [Google Scholar]
5. Bioactive natural products in cancer prevention and therapy: Progress and promise. Bishayee, A.; Sethi, G., Eds.; Seminars in cancer biologyElsevier2016
   [Google Scholar]
6. NewellM. MackeyJ.R. BigrasG. CamachoA.M. GorukS. GhoshS. SchmidtA. MiedeD. ChisottiA. PostovitL. BakerK. MazurakV. CourneyaK. BerendtR. DongW.F. WoodG. BasiS.K. JoyA.A. KingK. Meza-JuncoJ. ZhuX. FieldC. Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): Protocol of a double-blind, phase II, randomised controlled trial.BMJ Open201999e03050210.1136/bmjopen‑2019‑03050231530611
   [Google Scholar]
7. HosseiniF. Reza SamM. JabbariN. Radiosensitivity of radioresistant colorectal cancer cells after treatment with docosahexaenoic acid and irradiation.Tehran Univ. Med. J.2014723
   [Google Scholar]
8. OuW. MulikR.S. AnwarA. McDonaldJ.G. HeX. CorbinI.R. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.Free Radic. Biol. Med.201711259760710.1016/j.freeradbiomed.2017.09.00228893626
   [Google Scholar]
9. KatoT. KolenicN. PardiniR.S. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status.Nutr. Cancer200758217818710.1080/0163558070132836217640164
   [Google Scholar]
10. ThompsonH.J. NeilE.S. McGinleyJ.N. FitzgeraldV.K. El BayoumyK. ManniA. Building a foundation for precision onco-nutrition: Docosahexaenoic acid and breast cancer.Cancers202114115710.3390/cancers1401015735008321
    [Google Scholar]
11. AsztalosI.B. GleasonJ.A. SeverS. GedikR. AsztalosB.F. HorvathK.V. DansingerM.L. Lamon-FavaS. SchaeferE.J. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: A randomized clinical trial.Metabolism201665111636164510.1016/j.metabol.2016.07.01027733252
    [Google Scholar]
12. BougnouxP. HajjajiN. FerrassonM.N. GiraudeauB. CouetC. Le FlochO. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: A phase II trial.Br. J. Cancer2009101121978198510.1038/sj.bjc.660544119920822
    [Google Scholar]
13. MuQ. XueY. LuY. ZhangY. ChengQ. WanJ. LiuP. LiuJ. Qu HuangC. TangL. Advances in the therapy of cerebral ischemia-reperfusion injury with natural product-based nanoparticles.Nano TransMed202212-4e913000910.26599/NTM.2022.9130009
    [Google Scholar]
14. LeiY. MayoM.S. CarlsonS.E. GajewskiB.J. Personalized medicine enrichment design for DHA supplementation clinical trial.Contemp. Clin. Trials Commun.2017511612210.1016/j.conctc.2017.01.00228217765
    [Google Scholar]
15. EcheverríaF. ValenzuelaR. RodasC.H.M. ValenzuelaA. Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources.Prostaglandins Leukot. Essent. Fatty Acids201712411010.1016/j.plefa.2017.08.00128870371
    [Google Scholar]
16. BrownawellA.M. HarrisW.S. HibbelnJ.R. KlurfeldD.M. NewtonI. YatesA. Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling.Nutr. Rev.200967739139710.1111/j.1753‑4887.2009.00212.x19566599
    [Google Scholar]